(Q42801344)

7 November 2017

A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line (English)

1 reference

7 November 2017

0 references

1 reference

Edwards PA

1

1 reference

7 November 2017

Smith CM

series ordinal

2

1 reference

7 November 2017

Neville AM

series ordinal

3

1 reference

7 November 2017

O'Hare MJ

series ordinal

4

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 August 1982

1 reference

European Journal of Immunology

7 November 2017

1 reference

7 November 2017

12

1 reference

7 November 2017

641-648

1 reference

7 November 2017

8

1 reference

describes a project that uses

7 November 2017

HMy.2 B

0 references

cites work

Some properties and applications of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

Generation of human monoclonal antibodies reactive with human mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

The use of lymphocytes from axillary lymph nodes of mastectomy patients to generate human monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

Human monoclonal antibody against Forssman antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

Production of Antibody to Tetanus Toxoid by Continuous Human Lymphoblastoid Cell Lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

Human monoclonal antibodies produced by immortalization with Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

Production of human hybridomas secreting antibodies to measles virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

The isolation of heterokaryons and hybrids by a selective system using irreversible biochemical inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

In vitro induction and measurement of hemolytic plaque forming cells in man.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

THE INOSINIC ACID PYROPHOSPHORYLASE ACTIVITY OF MOUSE FIBROBLASTS PARTIALLY RESISTANT TO 8-AZAGUANINE

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

The binding of anti-immunoglobulin antibodies to rat thymocytes and thoracic duct lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

Diploid Azaguanine-Resistant Mutants of Cultured Human Fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

Separation and quantitation of lactic dehydrogenase isoenzymes by disc electrophoresis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

Antigen-specific induction and regulation of antibody synthesis in cultures of human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

Human hybridomas from malignant gliomas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830120804

7 January 2021

Identifiers

DOI

10.1002/EJI.1830120804

1 reference

7 November 2017

1 reference